Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Moderate to Severe Rheumatoid Arthritis”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06972446
What this trial is testing

Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
AbbVie 180
Large-scale testing (Phase 3)Active Not RecruitingNCT06276998
What this trial is testing

LNK01001 Capsule in Subjects With Active Rheumatoid Arthritis (COURAGE-RA)

Who this might be right for
Rheumatoid Arthritis
Lynk Pharmaceuticals Co., Ltd 430
Large-scale testing (Phase 3)Study completedNCT02706873
What this trial is testing

Compare Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have Not Previously Taken Methotrexate

Who this might be right for
Rheumatoid Arthritis
AbbVie 1,002
Testing effectiveness (Phase 2)Study completedNCT07335952
What this trial is testing

Proximod, a Selective Sphingosine-1-phosphate Receptor 1 Modulator in Patients With Moderate-to-severe Active Rheumatoid Arthritis: a Double-blind, Randomised, Placebo-controlled, Phase 2 Trial.

Who this might be right for
Rheumatoid Arthritis
Peking University People's Hospital 179
Not applicableStudy completedNCT05572567
What this trial is testing

Study to Evaluate Safety and Effects of Tofacitinib and Biologic Disease Modifying Antirheumatic Drugs in People Treated for Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Pfizer 1,972
Large-scale testing (Phase 3)Study completedNCT03789292
What this trial is testing

Compare Efficacy and Safety of CT-P17 With Humira in Patients With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Celltrion 648
Large-scale testing (Phase 3)Study completedNCT04512001
What this trial is testing

MSB11456 in Participants With Moderately to Severely Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Fresenius Kabi SwissBioSim GmbH 604
Testing effectiveness (Phase 2)Looking for participantsNCT07408024
What this trial is testing

Safety and Efficacy of TollB-001 Tablets in Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)
Toll Biotech Co. Ltd. (Beijing) 24
Testing effectiveness (Phase 2)Study completedNCT06099535
What this trial is testing

LNK01001 Capsule in Moderately to Severely Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Lynk Pharmaceuticals Co., Ltd 156
Early research (Phase 1)Study completedNCT05232396
What this trial is testing

Clinical Study of Single Dose IL-6R mAb Injection in RA Patients

Who this might be right for
Rheumatoid Arthritis
Beijing VDJBio Co., LTD. 40
Testing effectiveness (Phase 2)Study completedNCT02504671
What this trial is testing

Study to Evaluate the Efficacy and Safety of GSK3196165 Plus Methotrexate in Subjects With Active Moderate-Severe Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
GlaxoSmithKline 222
Testing effectiveness (Phase 2)Ended earlyNCT06859294
What this trial is testing

LY3541860 in Adult Participants With Moderately to Severely Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 35
Large-scale testing (Phase 3)Study completedNCT03120949
What this trial is testing

Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
R-Pharm International, LLC 2,106
Large-scale testing (Phase 3)Study completedNCT06738719
What this trial is testing

Evaluate Efficacy & Safety of Subcutaneous CT-P13 in Patients With Moderate to Severe Active Rheumatoid Arthritis

Who this might be right for
Moderately to Severely Active Rheumatoid Arthritis
Celltrion 192
Testing effectiveness (Phase 2)Ended earlyNCT03001219
What this trial is testing

RO7123520 to Evaluate the Safety and Efficacy in Participants With Moderately To Severely Active Rheumatoid Arthritis (RA) Who Are Inadequately Responding to Anti-Tumor Necrosis Factor (TNF)-Alpha Therapy

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 109
Large-scale testing (Phase 3)Study completedNCT02873936
What this trial is testing

Filgotinib Versus Placebo in Adults With Active Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Biologic Disease-modifying Anti-rheumatic Drug(s) (DMARDs) Treatment

Who this might be right for
Rheumatoid Arthritis
Gilead Sciences 449
Early research (Phase 1)Ended earlyNCT06087406
What this trial is testing

A Phase 1b Study of Imvotamab in Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid ArthritisArthritis, RheumatoidArthritis
IGM Biosciences, Inc. 33
Large-scale testing (Phase 3)Study completedNCT00106574
What this trial is testing

Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 1,220
Post-approval studies (Phase 4)Study completedNCT04928066
What this trial is testing

The Efficacy and Safety of Tofacitinib (TF) With Iguratimod (IGU) on RA

Who this might be right for
Arthritis, Rheumatoid
Qilu Hospital of Shandong University 100
Testing effectiveness (Phase 2)Study completedNCT01888874
What this trial is testing

Dose-finding Study of GLPG0634 as add-on to Methotrexate in Active Rheumatoid Arthritis Participants (DARWIN1)

Who this might be right for
Rheumatoid Arthritis
Lakefront Biotherapeutics NV 599
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation